Literature DB >> 223706

The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.

H E Barber, T N Calvey, K T Muir.   

Abstract

1 The relationship between the concentration of drug in plasma, the inhibition of erythrocyte acetylcholinesterase and the facilitation of neuromuscular transmission has been studied in the rat after the administration of neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethyl-ammonium (3-OH PTMA). 2 After the administration of neostigmine or pyridostigmine, acetylcholinesterase activity recovered only slowly due to the covalent nature of the inhibition. In contrast, recovery from the reversible inhibition caused by edrophonium or 3-OH PTMA was rapid and showed a direct relationship to the plasma concentration of these drugs. 3 There was a statistically significant linear correlation between the logarithm of the plasma concentration of the drugs and the increase in the tibialis twitch tension. 4 The relationship between the inhibition of acetylcholinesterase and the facilitation of neuromuscular transmission was complex. When the enzyme was less than 85% inhibited no facilitation occurred. Between 85% and 98% inhibition, facilitation was linearly related to enzyme inhibition. Above 98% inhibition, facilitation was unrelated to inhibition of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223706      PMCID: PMC2043590          DOI: 10.1111/j.1476-5381.1979.tb13690.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  The relationship between cholinesterase inhibition and drug-induced faciliation of mammalian neuromuscular transmission.

Authors:  A S KUPERMAN; E W GILL; W F RIKER
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

2.  Antagonism of tubocurarine. III. Time course of action of pyridostigmin, neostigmine, and edrophonium in vivo and in vitro.

Authors:  C M SMITH; J C MEAD; K R UNNA
Journal:  J Pharmacol Exp Ther       Date:  1957-06       Impact factor: 4.030

3.  Anticurare action of phenolic quaternary ammonium salts.

Authors:  L O RANDALL
Journal:  J Pharmacol Exp Ther       Date:  1950-09       Impact factor: 4.030

4.  The mechanism of anticurare action of certain neostigmine analogues.

Authors:  F HOBBIGER
Journal:  Br J Pharmacol Chemother       Date:  1952-06

5.  Pharmacological properties of some neostigmine analogs.

Authors:  L O RANDALL; G LEHMANN
Journal:  J Pharmacol Exp Ther       Date:  1950-05       Impact factor: 4.030

6.  Pyridostigmine metabolism in man.

Authors:  S M Somani; J B Roberts; A Wilson
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

7.  The use of liquid cation exchange in the extraction and separation of ( 14 C)neostigmine iodide and its metabolite ( 14 C)3-hydroxyphenyltrimethylammonium iodide from body fluids.

Authors:  H E Barber; G R Bourne; G A Buckley
Journal:  J Pharm Pharmacol       Date:  1972-11       Impact factor: 3.765

8.  Evaluation of curarizing drugs in man. V. Antagonism to curarizing effects of d-tubocurarine by neostigmine, m-hydroxy phenyltrimethylammonium and m-hydroxy phenylethyldimethylammonium.

Authors:  D W MacFARLANE; E W PELIKAN; K R UNNA
Journal:  J Pharmacol Exp Ther       Date:  1950-11       Impact factor: 4.030

9.  Determination of blood acetylcholinesterase inhibition caused by reversible inhibitors in vivo.

Authors:  M H Smith
Journal:  Biochem Med       Date:  1974-07

10.  The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.

Authors:  D J Back; T N Calvey
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

View more
  7 in total

1.  Accelerated reversal of pancuronium blockade with divided administration of neostigmine.

Authors:  S Inoue; N Ueda; H Tsuda; T Muteki
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

2.  Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

3.  Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

4.  Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

5.  Accelerated reversal of atracurium blockade with divided doses of neostigmine.

Authors:  M Abdulatif; M Naguib
Journal:  Can Anaesth Soc J       Date:  1986-11

6.  Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.

Authors:  M Naguib
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 7.  Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.

Authors:  Giovanni Di Nardo; Federica Viscogliosi; Francesco Esposito; Vincenzo Stanghellini; Maria Pia Villa; Pasquale Parisi; Alessia Morlando; Girolamo Caló; Roberto De Giorgio
Journal:  J Neurogastroenterol Motil       Date:  2019-10-30       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.